AIT (allergen immunotherapy): a model for the “precision medicine”
作者： Giovanni Passalacqua , Giorgio Walter Canonica
DOI: 10.1186/S12948-015-0028-6
关键词:
摘要: The interpretation of medical approaches, especially therapy, evolved rapidly in the last century. Starting from simple description symptoms, we moved to pathophysiological descriptions, evidence-based medicine, until so-called “precision medicine”. This latter can be defined as a structural model aimed at customizing healthcare, with decisions/products tailored on an individual patient highly detailed level. In this sense, allergen immunotherapy represents optimal medicine”, since know and describe function, aetiological agents molecular level, have possibility intervene natural history disease. If considered under point view pharmaco-economy, that is prescribing treatment right patient, almost-ideal precision medicine.
biomedcentral.com
springer.com
core.ac.uk
sci-hub.se 参考文章(28)
J. Larry Jameson, Dan L. Longo, Precision Medicine — Personalized, Problematic, and Promising The New England Journal of Medicine. ,vol. 372, pp. 2229- 2234 ,(2015) , 10.1056/NEJMSB1503104
Marek Jutel, Ioana Agache, Sergio Bonini, A. Wesley Burks, Moises Calderon, Walter Canonica, Linda Cox, Pascal Demoly, Antony J. Frew, Robin O'Hehir, Jörg Kleine-Tebbe, Antonella Muraro, Gideon Lack, Désirée Larenas, Michael Levin, Harald Nelson, Ruby Pawankar, Oliver Pfaar, Ronald van Ree, Hugh Sampson, Alexandra F. Santos, George Du Toit, Thomas Werfel, Roy Gerth van Wijk, Luo Zhang, Cezmi A. Akdis, International consensus on allergy immunotherapy The Journal of Allergy and Clinical Immunology. ,vol. 136, pp. 556- 568 ,(2015) , 10.1016/J.JACI.2015.04.047
Giovanni Passalacqua, Giorgio Walter Canonica, Sublingual immunotherapy: focus on tablets Annals of Allergy Asthma & Immunology. ,vol. 115, pp. 4- 9 ,(2015) , 10.1016/J.ANAI.2015.03.022
S. Kaul, S. May, D. Lüttkopf, S. Vieths, Regulatory environment for allergen‐specific immunotherapy Allergy. ,vol. 66, pp. 753- 764 ,(2011) , 10.1111/J.1398-9995.2011.02552.X
Allan R. Brasier, Identification of Innate Immune Response Endotypes in Asthma: Implications for Personalized Medicine Current Allergy and Asthma Reports. ,vol. 13, pp. 462- 468 ,(2013) , 10.1007/S11882-013-0363-Y
J. Lister, Antiseptic principle in the practice of surgery. BMJ. ,vol. 2, pp. 9- 12 ,(1967) , 10.1136/BMJ.2.5543.9
Yao Liu, Song Zhang, Dao-wei Li, Shu-juan Jiang, Efficacy of Anti-Interleukin-5 Therapy with Mepolizumab in Patients with Asthma: A Meta-Analysis of Randomized Placebo-Controlled Trials PLoS ONE. ,vol. 8, pp. e59872- ,(2013) , 10.1371/JOURNAL.PONE.0059872
A. Wesley Burks, Moises A. Calderon, Thomas Casale, Linda Cox, Pascal Demoly, Marek Jutel, Harold Nelson, Cezmi A. Akdis, Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report The Journal of Allergy and Clinical Immunology. ,vol. 131, pp. 1288- 1296 ,(2013) , 10.1016/J.JACI.2013.01.049
Joaquín Sastre, Marina Sastre-Ibañez, Molecular diagnosis and immunotherapy Current Opinion in Allergy and Clinical Immunology. ,vol. 16, pp. 565- 570 ,(2016) , 10.1097/ACI.0000000000000318
F. Braido, S. Holgate, G.W. Canonica, From “blockbusters” to “biosimilars”: An opportunity for patients, medical specialists and health care providers Pulmonary Pharmacology & Therapeutics. ,vol. 25, pp. 483- 486 ,(2012) , 10.1016/J.PUPT.2012.09.005